Cognitive dysfunction in multiple sclerosis: Usually forgotten in the clinical assessment of MS patients

by Seyed Massood Nabavi, Bahram Sangelaji
Published 2015-01-01

Changes in mitochondrial function in patients with neuromyelitis optica; correlations with motor and cognitive disabilities.

by Forough Foolad, Fariba Khodagholi, Seyed Massood Nabavi, Mohammad Javan
Published 2020-01-01

Prevalence of sexual dysfunction in men with multiple sclerosis: a systematic review and meta-analysis

by Maryam Dastoorpoor, Maryam Zamanian, Rahmatollah Moradzadeh, Seyed Massood Nabavi, Raana Kousari
Published 2021-01-01

Pregnancy and Motherhood Concerns Surrounding Women with Multiple Sclerosis: A Qualitative Content Analysis

by Faezeh Ghafoori, Nahid Dehghan Nayeri, Zohreh Khakbazan, Mahmoud Hedayatnejad, Seyed Massood Nabavi
Published 2020-01-01

Psychometric Properties of the Persian Version of the Fatigue Impact Scale (FIS-P) in Patients with Multiple Sclerosis

by Marzieh Heidari, Seyed Massood Nabavi, Malahat Akbarfahimi, Masoud Salehi, Mohammad Torabi-Nami
Published 2015-09-01

A self-administered, artificial intelligence (AI) platform for cognitive assessment in multiple sclerosis (MS)

by Seyed-Mahdi Khaligh-Razavi, Maryam Sadeghi, Mahdiyeh Khanbagi, Chris Kalafatis, Seyed Massood Nabavi
Published 2020-05-01

The Association between Urinary Disorder, Hypertonia and Assistive Device Usage with Falling in Individual with Multiple Sclerosis

by Mahsa Kosari Nejad, Shohreh Noorizadeh Dehkordi, Mehdi Dadgoo, Afsoon Hassani Mehraban, Massood Nabavi
Published 2014-01-01

Menstrual Irregularities and Related Plasma Hormone Levels in Multiple Sclerosis Patients Treated with Beta Interferone

by Seyed Massood Nabavi, Shideh Abedi Koupai, Mohammad Reza Nejati, Ehya Garshasbi, Mohammad Reza Jalali
Published 2010-02-01

Menstrual Irregularities and Related Plasma Hormone Levels in Multiple Sclerosis Patients Treated with Beta Interferone

by Ehya Garshasbi, Mohammad Reza Jalali, Seyed Massood Nabavi, Shideh Abedi Koupai, Mohammad Reza Nejati
Published 2010-02-01

Heat Shock Protein 70 And The Risk Of Multiple Sclerosis In The Iranian Population

by Seyedeh Parisa Chavoshi Tarzjani, Seyed Abolhassan Shahzadeh Fazeli, Mohammad Hossein Sanati, Seyed Massood Nabavi
Published 2018-08-01

Environmental air pollution and acute cerebrovascular complications: an ecologic study in Tehran, Iran

by Seyed Massood Nabavi, Batoul Jafari, Mozhgan Sadat Jalali, Saharnaz Nedjat, Khosro Ashrafi, Alireza Salahesh
Published 2012-01-01

Sexual Self-Efficacy and its Predictor Factors in Women with Multiple Sclerosis

by Vida Ghasemi, Masoumeh Simbar, Giti Ozgoli, Seyed Massood Nabavi, Hamid Alavi-Majd, Maryam Sadat Mirshafaei
Published 2019-08-01

Association of New Putative Epitopes of Myelin Proteolipid Protein (58-74) with Pathogenesis of Multiple Sclerosis

by Zahra Zamanzadeh, Ghasem Ahangari, Mitra Ataei, Samie Pouragahi, Seyed Massood Nabavi, Mehdi Sadeghi, Mohammad Hossein Sanati
Published 2016-10-01

Sexual dysfunction and predisposing factors in women with multiple sclerosis

by Khadijeh Mohammadi, Parvin Rahnama, Sakineh Moayed Mohseni, Soghrat Faghihzadeh, Mohammad Ali Sahraean, Shafigheh Mohammadi Tabar, Massood Nabavi
Published 2013-02-01

Safety, Feasibility Of Intravenous And Intrathecal Injection Of Autologous Bone Marrow Derived Mesenchymal Stromal Cells In Patients With Amyotrophic Lateral Sclerosis: An Open Lab...

by Seyed Massood Nabavi, Leila Arab, Neda Jarooghi, Tina Bolurieh, Fatemeh Abbasi, Soura Mardpour, Vajihe Azimyian, Fatemeh Moeininia, Saman Maroufizadeh, Leila Sanjari, Seyedeh Esmat Hosseini, Nasser Aghdami
Published 2018-08-01

MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of m...

by Antonio Uccelli, Alice Laroni, Lou Brundin, Michel Clanet, Oscar Fernandez, Seyed Massood Nabavi, Paolo A. Muraro, Roberto S. Oliveri, Ernst W. Radue, Johann Sellner, Per Soelberg Sorensen, Maria Pia Sormani, Jens Thomas Wuerfel, Mario A. Battaglia, Mark S. Freedman, on behalf of the MESEMS study group
Published 2019-05-01